Frequency of cardiogenic shock in acute inferior wall myocardial infarction.
Keywords:Acute inferior wall MI, hospital stay, cardiogenic shock, frequency
Background: Coronary heart disease (CHD) or atherosclerotic coronary artery disease has highest mortality rate United States and Worldwide1. It is expected that the projected increase in coronary heart disease will be much higher in South Asia as compared to other regions worldwide. In South Asia, it is expected to more than double over the next 20 years2.
Objective: The objective of the study was to determine the frequency of cardiogenic shock in acute inferior wall MI cases during hospital stay.
Material and Method: This descriptive case series involved 100 patients and was conducted at the Cardiology department of Mayo Hospital Lahore from Jan 2018 to –Dec 2018. Patient’s age, gender and presence of cardiogenic shock wasnoted. Data was analyzed using SPSS.
Results: Mean age was 56.24+9.38 years. 57% were male and 43% were females. Cardiogenic shock was seen in 28% of cases.
Conclusion: The frequency of cardiogenic shock is significant among patients with acute inferior wall MI cases during hospital stay. Therefore, it is recommended that every patient presenting with acute inferior wall MI, should be sort out for cardiogenic shock.
Keywords: Acute inferior wall MI, hospital stay, cardiogenic shock, frequency.
BashoreTB, Granger CB, Hranitzky P, Peter MR. Heart disease. In: McPhee SJ, PapadakisMA, editors.Current medical diagnosis and treatment. 49thed. Newyork: McGrawHill; 2010:294-386
Saleheen D, Zaidi M, Rasheed A, Ahmad U, Hakeem A, Murtaza M. The Pakistan risk of myocardial infarction study: A resource for the study of genetic, lifestyle and other determinants of myocardial infarction in south Asia. Eur J Epidemiol2009;24(6):329-38.
Jim MH, Chan AO, Tse HF, Lau CP. Predictors of in-hospital outcome after acute inferior wall myocardial infarction. Singapore Med J 2009;50(10):956-61
Menon V, Hochman JS. Management of cardiogenic shock complicating acute myocardial infarction. Heart. 2002; 88:531–7
Galla JM, Mukherjee D.Complications of myocardial infarction. In: Griffin BP, Topol EJ, editors. Manual of cardiovascular medicine. 3rd ed. Philadelphia: Lippincott Williams &Wilkins; 2009:48-66.
Antman EM, Morrow DA. ST Segment elevation myocardial infarction. In: Libby P, O. Bonow R, L. Mann D, P. Zipes D, editors. Braunwald's Heart Disease: A textbook of cardiovascular medicine. 9th ed. Philadelphia: Saunders Elsevier; 2011:1111-71.
Assali AR, Teplitsky I, Ben-Dor I, Solodky A, Brosh D. Prognostic importance of right ventricular infarction in an acute myocardial infarction cohort referred for contemporary percutaneous reperfusion therapy. Am Heart J 2007; 153:231-7.
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2:349-360
Kennedy JW, Martin GV, Davis KB, Maynard C, Stadius M, Sheehan FH, Ritchie JL: The Western Washington intravenous streptokinase in acute myocardial infarction randomized trial. Circulation 1988; 77:345-52
Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999; 340:1162–8.
Malla RR, Sayami A. In hospital complications and mortality of patients of inferior wall myocardial infarction with right ventricular infarction. L Nepal Med Assoc 2007;46(167):99-102.
Rodrigues A, Arujao D. Primary angioplasty for acute myocardial infarction complicated by cardiogenic shock on admission. Rev Port Cardiol 2000; 19:291.
Fida Z. Complications with acute inferior wall myocardial infarction. JPMI 2004; 18:202-5.
Bueno H, López-Palop R, Bermejo J, José L. López-Sendón, Juan L. In-Hospital Outcome of Elderly Patients with Acute Inferior Myocardial Infarction and Right Ventricular Involvement. Circulation 1997; 96:436-41